一线转移性结直肠癌的风险调整CT时间表。

IF 65.4 1区医学 Q1 ONCOLOGY

Annals of Oncology Pub Date : 2025-09-23 DOI:10.1016/j.annonc.2025.09.010

R Salazar, A Carmona-Bayonas

引用次数: 0

摘要

总之，本研究为mCRC的风险调整随访提供了令人信服的循证基础，挑战了过时的监测节奏。它使我们离精确肿瘤学更近了一步——这次不是在治疗选择上，而是在监测策略上。它提供了一种实用的启发式方法：将监测重点放在6-10个月左右，根据肿瘤生物学进行调整，并使用ETS来优化时间——同时认识到它仍然是一个人口水平的指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Toward risk-adjusted CT schedules in first-line metastatic colorectal cancer.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annals of Oncology 医学-肿瘤学

CiteScore

63.90

自引率

1.00%

发文量

3712

审稿时长

2-3 weeks

期刊介绍： Annals of Oncology, the official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, offers rapid and efficient peer-reviewed publications on innovative cancer treatments and translational research in oncology and precision medicine. The journal primarily focuses on areas such as systemic anticancer therapy, with a specific emphasis on molecular targeted agents and new immune therapies. We also welcome randomized trials, including negative results, as well as top-level guidelines. Additionally, we encourage submissions in emerging fields that are crucial to personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Manuscripts related to radiotherapy, surgery, and pediatrics will be considered if they demonstrate a clear interaction with any of the aforementioned fields or if they present groundbreaking findings. Our international editorial board comprises renowned experts who are leaders in their respective fields. Through Annals of Oncology, we strive to provide the most effective communication on the dynamic and ever-evolving global oncology landscape.